For patients with advanced lung cancer, liquid biopsy predicts immunotherapy response and toxicity.

Published Date: 13 Dec 2023

Doctors may be able to identify patients with advanced lung cancer who are responding to immunotherapies by using a "liquid biopsy" to examine genetic material from tumors released into the bloodstream along with immune cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Reducing social media to an hour a day boosts young people's self-image.

2.

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

3.

The pandemic had little impact on mental health symptoms.

4.

FDA Approves New Bladder Cancer First-Line Standard of Care.

5.

A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot